Revelation Biosciences Stock Current Asset
| REVBW Stock | USD 0.01 0 22.89% |
Revelation Biosciences fundamentals help investors to digest information that contributes to Revelation Biosciences' financial success or failures. It also enables traders to predict the movement of Revelation Stock. The fundamental analysis module provides a way to measure Revelation Biosciences' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Revelation Biosciences stock.
Non Current Assets Total is likely to climb to about 59.1 M in 2025. Other Current Assets is likely to climb to about 70 M in 2025. Revelation | Current Asset |
Revelation Biosciences Company Current Asset Analysis
Revelation Biosciences' Current Asset is all of the company's assets that can be used to pay off current liabilities within the current fiscal period or over the next 12 months. Current Asset includes cash or cash equivalents, accounts receivable, short-term investments, and the portion of prepaid liabilities which will be paid within the next 12 months. Because these assets are easily turned into cash, they are sometimes referred to as liquid assets.
Revelation Current Asset Historical Pattern
Today, most investors in Revelation Biosciences Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Revelation Biosciences' growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's current asset growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Revelation Biosciences current asset as a starting point in their analysis.
Revelation Biosciences Current Asset |
| Timeline |
Current Asset is important to company's creditors and private equity firms as they will often be interested in how much that company has in current assets since these assets can be easily liquidated in case the company goes bankrupt. However, it is usually not enough to know if a company is in good shape just based on current asset alone; the amount of current liabilities should always be considered.
| Competition |
Revelation Total Assets
Total Assets |
|
In accordance with the recently published financial statements, Revelation Biosciences has a Current Asset of 0.0. This is 100.0% lower than that of the Biotechnology sector and 100.0% lower than that of the Health Care industry. The current asset for all United States stocks is 100.0% higher than that of the company.
Did you try this?
Run Instant Ratings Now
Instant RatingsDetermine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |
| All Next | Launch Module |
Revelation Fundamentals
| Return On Equity | -2.65 | ||||
| Return On Asset | -0.53 | ||||
| Number Of Shares Shorted | 14.14 K | ||||
| EBITDA | (7.98 B) | ||||
| Net Income | (15.04 B) | ||||
| Cash And Equivalents | 4.14 M | ||||
| Cash Per Share | 1.79 X | ||||
| Total Debt | 1.91 B | ||||
| Debt To Equity | 0.01 % | ||||
| Current Ratio | 2.58 X | ||||
| Book Value Per Share | 9.02 X | ||||
| Cash Flow From Operations | (18.32 B) | ||||
| Earnings Per Share | (4.77) X | ||||
| Beta | 0.18 | ||||
| Total Asset | 6.62 B | ||||
| Retained Earnings | (40.51 B) | ||||
| Working Capital | 4.65 M | ||||
| Net Asset | 6.62 B |
About Revelation Biosciences Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Revelation Biosciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Revelation Biosciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Revelation Biosciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Revelation Stock Analysis
When running Revelation Biosciences' price analysis, check to measure Revelation Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Revelation Biosciences is operating at the current time. Most of Revelation Biosciences' value examination focuses on studying past and present price action to predict the probability of Revelation Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Revelation Biosciences' price. Additionally, you may evaluate how the addition of Revelation Biosciences to your portfolios can decrease your overall portfolio volatility.